NCT03501017

Brief Summary

Objective: The aim of the first part of this study with two stages is to determine prevalence of CVD risk and the associated variables in individuals aged 40-65 years registered in a Family Health Center (FHC) in city center of Antalya; the aim of the second one is to evaluate the effect of intervention to increase physical activity in individuals with moderate risk of CVD on decreasing the risk level. Methods: Stage 1 and Stage 2 were conducted as cross-sectional and Randomized Controlled Experimental Trial, respectively. In the first stage the CVD risk level was calculated using the HeartScore. In the second stage, 11 individuals with moderate CVD risk (2-\<5%) found in the intervention group participated into a 12-week physical activity program (a moderate walk outdoor, with group 5 days in a week, each lasting for 40 minutes) guided by nurse. CVD brochure and physical activity guide was distributed to 11 individuals in control group within the scope of routine practice of FHCs.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2016

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 20, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2016

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 2, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 18, 2018

Completed
Last Updated

April 18, 2018

Status Verified

April 1, 2018

Enrollment Period

4 months

First QC Date

April 2, 2018

Last Update Submit

April 10, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in CVD risk level

    "HeartScore® program" was used to determine the CVD risk level in the first stage of the study. In the second part, the risk level was evaluated using HeartScore program for the second time. HeartScore® is a primary prevention tool that provides risk measurement for people who have not had any cardiovascular disease. According to the SCORE score calculated in the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice, individuals are divided into 4 risk categories. Accordingly, if SCORE score is; * ≥%10, very high risk category, * Between ≥%5- \<%10, high risk category * Between ≥%2- \<5, moderate risk category, * \<%1, then they are in the low risk category.

    12 week

Secondary Outcomes (2)

  • Change in Opinions and Experiences about Physical Activity

    12 week

  • Change in Physical activity level

    12 week

Study Arms (2)

Intervention group

EXPERIMENTAL

The 12-week physical activity program was implemented under the guidance of nurse, in outdoors with the group, 5 days a week with warm up and cooling down for 10 minutes and normal walking tempo at a moderate pace for 30-45 minutes (3-6 km/hour).

Other: physical activity program

Control Group

ACTIVE COMPARATOR

As routine practice, a brochure provided from the Public Health Directorate on protection from CVD was delivered to the individuals in the control group.

Other: Routine Practice

Interventions

The 12-week physical activity program was implemented under the guidance of nurse, in outdoors with the group, 5 days a week with warm up and cooling down for 10 minutes and normal walking tempo at a moderate pace for 30-45 minutes (3-6 km/hour). Application of WHO Smoking Cessation Algorithm: After fagerström test was applied, the modified smoking cessation algorithm of WHO was applied to the individuals and those who decided to quit smoking were referred to smoking cessation outpatient clinics.

Intervention group

As routine practice, a brochure provided from the Public Health Directorate on protection from CVD was delivered to the individuals in the control group.

Control Group

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being aged between 40 and 65 years,
  • Not having a problem that could prevent walking activity,
  • Being voluntary to participate in the study.

You may not qualify if:

  • Having a known and diagnosed CVD, being diagnosed with diabetes (they are evaluated to have a high risk in the European Guidelines on Cardiovascular Disease Prevention and treatment is recommended),
  • Having walking disabled,
  • Not being voluntary to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Motor ActivityRisk Reduction Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Sebahat Gözüm, Prof

    Akdeniz University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 2, 2018

First Posted

April 18, 2018

Study Start

June 20, 2016

Primary Completion

October 25, 2016

Study Completion

December 20, 2016

Last Updated

April 18, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share